The company had posted a revenue of Rs 791.3 crore for the fiscal year 2015-16.
"We are aiming for around 18% growth in the current fiscal. We have been growing at that rate and will like to keep the momentum," Dr Lal PathLabs CEO Om Manchanda told PTI.
Also Read
The company will at the same time focus on providing better services,introducing new tests. It currently conducts nearly 2,000 tests, he added.
When asked how the company planned to fund the expansion, Manchanda said: "It will be through internal accruals. We have sufficient funds."
While deepening its presence in the North Indian market where it already has a strong presence, the company is also looking to scale up in other parts of the country as well.
"Banking on our leadership in northern India, we are assertively moving into other potentially good geographies, the first of which will be East and Central India," he added.
The company also plans to expand in to South and West India.
"In south and west we have selected two cities Bengaluru and Pune. In these cities we will develop critical mass and then expand," Manchanda said.
Dr LalPath Labs has 172 clinical labs and one central laboratory, over 1,500 collection centres and 4,967 pick-up points.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)